WO2005107364A3 - Nouvelles sequences de nucleotides et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic - Google Patents

Nouvelles sequences de nucleotides et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic Download PDF

Info

Publication number
WO2005107364A3
WO2005107364A3 PCT/IB2005/002407 IB2005002407W WO2005107364A3 WO 2005107364 A3 WO2005107364 A3 WO 2005107364A3 IB 2005002407 W IB2005002407 W IB 2005002407W WO 2005107364 A3 WO2005107364 A3 WO 2005107364A3
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotide
polypeptides
diagnostic methods
methods
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2005/002407
Other languages
English (en)
Other versions
WO2005107364A2 (fr
WO2005107364A9 (fr
Inventor
Amir Toporik
Sarah Pollock
Zurit Levine
Michal Ayalon-Soffer
Gad S Cojocaru
Alexander Diber
Amit Novik
Dvir Dahary
Pinchas Akiva
Rotem Sorek
Ronen Shemesh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Compugen USA Inc
Original Assignee
Compugen USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Compugen USA Inc filed Critical Compugen USA Inc
Priority to EP05767217A priority Critical patent/EP1735342A2/fr
Priority claimed from US11/043,806 external-priority patent/US7368548B2/en
Publication of WO2005107364A2 publication Critical patent/WO2005107364A2/fr
Publication of WO2005107364A9 publication Critical patent/WO2005107364A9/fr
Anticipated expiration legal-status Critical
Publication of WO2005107364A3 publication Critical patent/WO2005107364A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention a trait à de nouveaux variants d'épissage, des séquences d'acides aminés de ceux-ci, et leurs procédés d'utilisation.
PCT/IB2005/002407 2004-01-27 2005-01-27 Nouvelles sequences de nucleotides et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic Ceased WO2005107364A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05767217A EP1735342A2 (fr) 2004-01-27 2005-01-27 Nouvelles sequences de nucleotides et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic

Applications Claiming Priority (50)

Application Number Priority Date Filing Date Title
US53912804P 2004-01-27 2004-01-27
US53912904P 2004-01-27 2004-01-27
US60/539,128 2004-01-27
US60/539,129 2004-01-27
US62100404P 2004-10-22 2004-10-22
US62087404P 2004-10-22 2004-10-22
US60/621,004 2004-10-22
US60/620,874 2004-10-22
US62107204P 2004-10-25 2004-10-25
US62105304P 2004-10-25 2004-10-25
US60/621,072 2004-10-25
US60/621,053 2004-10-25
US62166304P 2004-10-26 2004-10-26
US60/621,663 2004-10-26
US62201704P 2004-10-27 2004-10-27
US62201604P 2004-10-27 2004-10-27
US62232004P 2004-10-27 2004-10-27
US60/622,320 2004-10-27
US60/622,017 2004-10-27
US60/622,016 2004-10-27
US62816504P 2004-11-17 2004-11-17
US62823104P 2004-11-17 2004-11-17
US62813404P 2004-11-17 2004-11-17
US62819004P 2004-11-17 2004-11-17
US62825104P 2004-11-17 2004-11-17
US62811204P 2004-11-17 2004-11-17
US62814504P 2004-11-17 2004-11-17
US62815604P 2004-11-17 2004-11-17
US62817904P 2004-11-17 2004-11-17
US62810104P 2004-11-17 2004-11-17
US62814404P 2004-11-17 2004-11-17
US62813304P 2004-11-17 2004-11-17
US60/628,112 2004-11-17
US60/628,145 2004-11-17
US60/628,190 2004-11-17
US60/628,133 2004-11-17
US60/628,251 2004-11-17
US60/628,144 2004-11-17
US60/628,156 2004-11-17
US60/628,165 2004-11-17
US60/628,179 2004-11-17
US60/628,231 2004-11-17
US60/628,134 2004-11-17
US60/628,101 2004-11-17
US63055904P 2004-11-26 2004-11-26
US60/630,559 2004-11-26
US63407504P 2004-12-08 2004-12-08
US60/634,075 2004-12-08
US11/043,806 2005-01-27
US11/043,806 US7368548B2 (en) 2004-01-27 2005-01-27 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer

Publications (3)

Publication Number Publication Date
WO2005107364A2 WO2005107364A2 (fr) 2005-11-17
WO2005107364A9 WO2005107364A9 (fr) 2006-05-11
WO2005107364A3 true WO2005107364A3 (fr) 2009-04-16

Family

ID=35335669

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/002407 Ceased WO2005107364A2 (fr) 2004-01-27 2005-01-27 Nouvelles sequences de nucleotides et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic

Country Status (2)

Country Link
EP (1) EP1735342A2 (fr)
WO (1) WO2005107364A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20075466A0 (fi) * 2007-06-19 2007-06-19 Chempath Oy Transmembraaninen eturauhasen hapan fosfataasi
AU2009333580B2 (en) 2008-12-09 2016-07-07 Genentech, Inc. Anti-PD-L1 antibodies and their use to enhance T-cell function

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014340A1 (fr) * 1997-09-19 1999-03-25 Incyte Pharmaceuticals, Inc. Phosphatase prl-1 humaine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014340A1 (fr) * 1997-09-19 1999-03-25 Incyte Pharmaceuticals, Inc. Phosphatase prl-1 humaine

Also Published As

Publication number Publication date
WO2005107364A2 (fr) 2005-11-17
WO2005107364A9 (fr) 2006-05-11
EP1735342A2 (fr) 2006-12-27

Similar Documents

Publication Publication Date Title
WO2006131928A3 (fr) Nouvelles sequences de nucleotides et d'acides amines, leurs dosages et methodes d'utilisation en vue du diagnostic
WO2005084116A3 (fr) Nouveaux variants du canal calcique et leurs procedes d'utilisation
WO2006009901A3 (fr) Nouveaux polypeptides de liaison a l'antigene et leurs utilisations
WO2007044026A3 (fr) Compositions comportant du collagène modifié et leurs utilisations
WO2006017538A3 (fr) Proteines de liaison a la proteine hk1
WO2004080148A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2008143668A3 (fr) Indoléamine-2, 3-dioxygénase-2
WO2006127757A3 (fr) Fusion interferon-igg
WO2007039903A3 (fr) Nouveaux nucleotides et nouvelles sequences d'acides amines, et bioessais et procedes d'utilisation associes a des fins de diagnostic
WO2006009649A3 (fr) Sequences de brassica indehiscent1
WO2004087874A3 (fr) Acides nucleiques et polypeptides
IL223076A0 (en) Novel as160-like protein, test systems, methods and uses involving it for the identification of diabetes type 2 therapeutics
WO2010051056A3 (fr) Polypeptides anti-fcεri et leurs utilisations
WO2005108428A3 (fr) Variants d'epissage de cd40 et leurs utilisations
WO2006135793A3 (fr) Obtention de proteines par ingenierie des proteines avec des environnements de contact analogues
WO2005049806A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2006054297A3 (fr) Nouvelles sequences nucleotidiques et d'acides amines, et leurs dosages et leurs procedes d'utilisation pour le diagnostic
WO2005000876A3 (fr) Proteines de la famille des proteines a doigts de zinc (ring finger) et leurs utilisations
AP2006003544A0 (en) Amino acids with affinity for the alpha2delta-protein.
WO2005107364A3 (fr) Nouvelles sequences de nucleotides et d'acides amines, et leurs dosages et procedes d'utilisation pour le diagnostic
WO2003055980A3 (fr) Molecules du type il-17 et utilisations associees
MX296535B (es) Enzima laccasa novedosa y uso de la misma.
WO2003091447A3 (fr) Acides nucleiques d1-1, polypeptides et methodes associees
WO2005059101A3 (fr) Nouveau canal sodique
WO2007107996A3 (fr) Nouvelles sequences de nucleotides et d'acides amines et leur procedes d'utilisation dans le cadre d'un diagnostic

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1429-1436, CLAIMS, REPLACED BY CORRECT PAGES 1429-1436

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2005767217

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 2005767217

Country of ref document: EP